Wiedemann‑Steiner syndrome in a 2‑year‑old patient due to a rare nonsense KMT2A mutation of de novo origin: A case report

Keramida,Christina; Papoulidis,Ioannis; Siomou,Elisavet; Efstathiadou,Chrisoula; Gyftodimou,Yolanda; Pavlidou,Efterpi; Anastasakis,Eleftherios; Garas,Antonios; Manolakos,Emmanouil

doi:10.3892/ije.2024.20

Wiedemann‑Steiner syndrome in a 2‑year‑old patient due to a rare nonsense KMT2A mutation of de novo origin: A case report

Authors:
- Christina Keramida
- Ioannis Papoulidis
- Elisavet Siomou
- Chrisoula Efstathiadou
- Yolanda Gyftodimou
- Efterpi Pavlidou
- Eleftherios Anastasakis
- Antonios Garas
- Emmanouil Manolakos
View Affiliations

Affiliations: Access to Genome P.C., Clinical Laboratory Genetics, 11527 Athens, Greece, Department of Speech and Language Therapy, University of Ioannina, 45110 Ioannina, Greece, IASO Maternity Hospital, 15123 Athens, Greece, Department of Obstetrics and Gynaecology, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41500 Larissa, Greece
Published online on: February 5, 2024 https://doi.org/10.3892/ije.2024.20
Article Number: 1
Copyright : © Keramida et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Wiedemann‑Steiner syndrome (WSS) is a genetic disorder characterized by a wide range of clinical symptoms, including developmental delay, intellectual disability, characteristic facial features, and other clinical features. It is part of group of disorders with an overlapping phenotypic spectrum known as chromatinopathies. WSS has been linked to heterozygous pathogenic mutations in the lysine methyltransferase 2A (KMT2A) gene that encodes a protein that is part of the epigenetic machinery. The present study reports the case of a 2‑year‑old female patient that presented with a variety of clinical features, including hypertelorism, thick eyebrows and epicanthus. Whole exome sequencing (WES) analysis was performed on the patient and the results revealed the presence of a rare heterozygous mutation in KMT2A, namely c.517C>T. The mutation was not detected in her parents, indicating that it occurred de novo in the patient. To the best of our knowledge, this is the first description of a patient with WSS due to the c.517C>T mutation. The present case report includes a detailed description of the phenotypic characteristics of the patient, which is crucial for genetic counseling in cases where this mutation is detected. Finally, the present study emphasizes the significance of utilizing WES for achieving differential diagnosis when a chromatinopathy is suspected.

View Figures

View References

1	Sheppard SE and Quintero-Rivera F: Wiedemann-Steiner Syndrome. University of Washington, Seattle, WA, 2022.
2	Yu H, Zhang G, Yu S and Wu W: Wiedemann-Steiner Syndrome: Case report and review of literature. Children (Basel). 9(1545)2022.PubMed/NCBI View Article : Google Scholar
3	Fahrner JA and Bjornsson HT: Mendelian disorders of the epigenetic machinery: Postnatal malleability and therapeutic prospects. Hum Mol Genet. 28(R2):R254–R264. 2019.PubMed/NCBI View Article : Google Scholar
4	Castiglioni S, Di Fede E, Bernardelli C, Lettieri A, Parodi C, Grazioli P, Colombo EA, Ancona S, Milani D, Ottaviano E, et al: KMT2A: Umbrella gene for multiple diseases. Genes (Basel). 13(514)2022.PubMed/NCBI View Article : Google Scholar
5	Lim DA, Huang YC, Swigut T, Mirick AL, Garcia-Verdugo JM, Wysocka J, Ernst P and Alvarez-Buylla A: Chromatin remodelling factor Mll1 is essential for neurogenesis from postnatal neural stem cells. Nature. 458:529–533. 2009.PubMed/NCBI View Article : Google Scholar
6	Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al: Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 17:405–424. 2015.PubMed/NCBI View Article : Google Scholar
7	Fontana P, Passaretti FF, Maioli M, Cantalupo G, Scarano F and Lonardo F: Clinical and molecular spectrum of Wiedemann-Steiner syndrome, an emerging member of the chromatinopathy family. World J Med Genet. 9:1–11. 2020.
8	Huang YC, Shih HY, Lin SJ, Chiu CC, Ma TL, Yeh TH and Cheng YC: The epigenetic factor Kmt2a/Mll1 regulates neural progenitor proliferation and neuronal and glial differentiation. Dev Neurobiol. 75:452–462. 2015.PubMed/NCBI View Article : Google Scholar
9	Yu BD, Hess JL, Horning SE, Brown GA and Korsmeyer SJ: Altered Hox expression and segmental identity in Mll-mutant mice. Nature. 378:505–508. 1995.PubMed/NCBI View Article : Google Scholar
10	Kim SY, Levenson JM, Korsmeyer S, Sweatt JD and Schumacher A: Developmental regulation of Eed complex composition governs a switch in global histone modification in brain. J Biol Chem. 282:9962–9972. 2007.PubMed/NCBI View Article : Google Scholar
11	Jakovcevski M, Ruan H, Shen EY, Dincer A, Javidfar B, Ma Q, Peter CJ, Cheung I, Mitchell AC, Jiang Y, et al: Neuronal Kmt2a/Mll1 histone methyltransferase is essential for prefrontal synaptic plasticity and working memory. J Neurosci. 35:5097–5108. 2015.PubMed/NCBI View Article : Google Scholar
12	Jones WD, Dafou D, McEntagart M, Woollard WJ, Elmslie FV, Holder-Espinasse M, Irving M, Saggar AK, Smithson S, Trembath RC, et al: De novo mutations in MLL cause wiedemann-steiner syndrome. Am J Hum Genet. 91:358–364. 2012.PubMed/NCBI View Article : Google Scholar
13	Bramswig NC, Lüdecke HJ, Alanay Y, Albrecht B, Barthelmie A, Boduroglu K, Braunholz D, Caliebe A, Chrzanowska KH, Czeschik JC, et al: Exome sequencing unravels unexpected differential diagnoses in individuals with the tentative diagnosis of Coffin-Siris and Nicolaides-Baraitser syndromes. Hum Genet. 134:553–568. 2015.PubMed/NCBI View Article : Google Scholar
14	Yuan B, Pehlivan D, Karaca E, Patel N, Charng WL, Gambin T, Gonzaga-Jauregui C, Sutton VR, Yesil G, Bozdogan ST, et al: Global transcriptional disturbances underlie Cornelia de Lange syndrome and related phenotypes. J Clin Invest. 125:636–651. 2015.PubMed/NCBI View Article : Google Scholar
15	Parenti I, Teresa-Rodrigo ME, Pozojevic J, Ruiz Gil S, Bader I, Braunholz D, Bramswig NC, Gervasini C, Larizza L, Pfeiffer L, et al: Mutations in chromatin regulators functionally link Cornelia de Lange syndrome and clinically overlapping phenotypes. Hum Genet. 136:307–320. 2017.PubMed/NCBI View Article : Google Scholar
16	Sobreira N, Brucato M, Zhang L, Ladd-Acosta C, Ongaco C, Romm J, Doheny KF, Mingroni-Netto RC, Bertola D, Kim CA, et al: Patients with a Kabuki syndrome phenotype demonstrate DNA methylation abnormalities. Eur J Hum Genet. 25:1335–1344. 2017.PubMed/NCBI View Article : Google Scholar
17	Negri G, Magini P, Milani D, Crippa M, Biamino E, Piccione M, Sotgiu S, Perrìa C, Vitiello G, Frontali M, et al: Exploring by whole exome sequencing patients with initial diagnosis of Rubinstein-Taybi syndrome: The interconnections of epigenetic machinery disorders. Hum Genet. 138:257–269. 2019.PubMed/NCBI View Article : Google Scholar